About
Turning complexity into conviction.
ChaosBio exists to bridge scientific innovation and successful company building in early-stage healthcare.
Mission
Science, capital, and execution.
Great science does not automatically become a durable company. ChaosBio works on the gap between the two: helping founders build credibility, helping investors evaluate risk, and helping healthcare leaders make better decisions where science, capital, and execution meet.
About Chao Zheng
An operator who invests.
Chao Zheng is a pharmaceutical R&D operator, angel investor, and advisor working with life sciences founders, investors, and executives in early-stage healthcare innovation.
His experience spans discovery research and development, project leadership, strategy, external innovation, and CMC execution — more than ten years inside the process that turns a scientific result into a medicine.
Connect on LinkedInInvestment Philosophy
Investors fund risk reduction.
Great science matters, but it is rarely the whole story. The work of an early-stage company is turning uncertainty into clear milestones across the science, the team, the development path, manufacturing, and the financing strategy.
Every review comes back to the same questions. Is the problem meaningful? Is the evidence credible? Is the path realistic? Is the team complete? And are the key risks being reduced in a way that investors, partners, and future acquirers can trust?
Angel Investing
Four areas of focus.
Therapeutics
Small molecules, biologics, and ATMPs targeting diseases with high unmet medical need.
Medical Devices
Novel medical devices that improve patient outcomes or create new standards of care.
Digital Health
AI and digital solutions that address clear clinical, workflow, or patient adoption problems.
Life Sciences Infrastructure
Technologies that accelerate, enable, or improve research, development, manufacturing, and commercialization across the life sciences ecosystem.
Seed and early-stage, where a pharma R&D background gives founders a real advantage in diligence, in coaching, and in the network around them.
Speaking & Mentoring
Working with founders and investors.
Chao writes and speaks on fundraising readiness, diligence, and translating healthcare innovation into companies — the same material that appears in the ChaosBio Journal. He mentors founders directly and is open to speaking with groups working on early-stage life science company building.
For anything else, the fastest route is email: contact@chaosbio.com.